SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Coherent (COHR) : Anyone else holding?
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
788 13 0 COHR
Emcee:  Marshall Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
413 I don't understand your comment, either. The co. spends quite a bit of itsKhris Vogel-1/21/1998
412 Doug, I'm puzzled by your response. I don't find the analogy to be selfDan Packer-1/21/1998
411 My preference regarding "optimising their cash flow" does not countDoug-1/20/1998
410 <i>"COHR tends to leave its excess cash as Retained earnings which mAndrew-1/20/1998
409 Dan Packer/Cash Flow. In certain Industries cash flow is fully utilised for AcDoug-1/20/1998
408 <<Price/Cash flow valuations would make sense if spending for AcquistionsDan Packer-1/19/1998
407 Thx Cytokine1 for that pointer. I too would like the stock to be treated as a hDoug-1/18/1998
406 Another small article: Follows from previously posted article link. thestreetCytokine1-1/18/1998
405 Price/Cash flow valuations would make sense if spending for Acquistions/R&amDoug-1/17/1998
404 A logical driver for COHR is its free cash flow. The question might be: as a Dan Packer-1/16/1998
403 You may not have to wait too long. The train is moving ; did you hear the whisDoug-1/16/1998
402 >>the next millineum will require nano technology<< Will that be bappro-1/15/1998
401 Unlike BAY,COHR has by tradition never been a Wall street favourite. It is haDoug-1/14/1998
400 Dear Doug, I would concur with Your analysis. However I think that the tech-selCrossy-1/14/1998
399 Crossy/ 2Q's I am comfortable with that analysis & strategy with 1 cavDoug-1/13/1998
398 Doug, sine the reason for me to enter COHR was lithographic products coming up,Crossy-1/13/1998
397 Cytokinel/"Incoherent" The Intra day pattern has certainly changed.Doug-1/13/1998
396 Article, "Incoherent Coherent" discusses roller-coaster market perforCytokine1-1/10/1998
395 Thanks, Brad. >>I can't market time, ever.<< Neither can I. :appro-1/9/1998
394 I absolutely love your daytrader admission. I can't market time, ever. My tBrad Zelnick-1/9/1998
393 >>without any milestone checks can be dangerous<< Doug, you are soappro-1/8/1998
392 appro/Timeframe Parking for years without any milestone checks can be dangerousDoug-1/8/1998
391 >>or is it "Abandon Ship"<< IMHO it depends on your timiappro-1/8/1998
390 Crossy/Clues in earnings Report. Your attention re: New Product revenues makes Doug-1/8/1998
389 Doug, mainly I would look for 1) Semicondunctor sales - (yet ??), or at least Crossy-1/8/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News